Abbott Wins Off-Label Stent Marketing Suit
This article was originally published in The Gray Sheet
A former Guidant salesman alleged the company marketed biliary stents off-label for use in vascular procedures. However, the company said Medicare knew biliary stents were the standard of care for arterial uses. A Texas jury sided with Abbott.
Register for our free email digests: